Sfoglia per Autore
Iper IgG4
2019-01-01 DELLA TORRE, E
La sindrome IgG4 una nuova sfida per l’internista e lo pneumologo
2019-01-01 DELLA TORRE, E
LONG-TERM EFFICACY OF RITUXIMAB MAINTENANCE THERAPY FOR IGG4- RELATED DISEASE RITUXIMAB MAINTENANCE THERAPY IN IGG4-RELATED DISEASE
2019-01-01 Campochiaro, C.; DELLA TORRE, E; Lanzillotta, M.; Bozzolo, E. P.; Baldissera, E.; Milani, R.; Arcidiacono, P. G.; Crippa, S.; Falconi, M.; Dagna, L.
CLINICAL MANIFESTATIONS OF IGG4-RELATED DISEASE ONSET REQUIRE ADMISSION TO THE EMERGENCY DEPARTMENT IN THE MAJORITY OF CASES. EXPERIENCE FROM A SINGLE ITALIAN REFERRAL CENTRE
2019-01-01 Mancuso, G.; Lanzillotta, M.; Campochiaro, C.; Ramirez, G. A.; Bozzolo, E. P.; Dagna, L.; DELLA TORRE, E
IMMUNOTERAPIA SPECIFICA E MALATTIA IgG4-CORRELATA: STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO
2019-01-01 DELLA TORRE, E; Germanò, Tommaso; Lanzillotta, Marco; Corrado, Campochiaro; Dagna, Lorenzo; Mona-Rita, Yacoub
Malattia IgG4 correlata
2019-01-01 DELLA TORRE, E
La Malattia da IgG4
2019-01-01 DELLA TORRE, E
Malattia sistemica e colangiopatia IgG4-relata
2019-01-01 DELLA TORRE, E
B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED DISEASE
2019-01-01 DELLA TORRE, E; E., Rigamonti1; C., Perugino2; S., Baghai Sain1; L., Rovati1; Lanzillotta1, M.; Stone2, J. H.; Manfredi1, A. A.; S., Pillai2
EFFICACY AND SAFETY OF RITUXIMAB FOR INDUCTION OF REMISSION AND MAINTENANCE OF IGG4-RELATED DISEASE: EXPERIENCE FROM AN ITALIAN NATIONAL REFERRAL CENTRE
2019-01-01 Corrado, Campochiaro; DELLA TORRE, E; Lanzillotta, Marco; Enrica, Bozzolo; Elena, Baldissera; Dagna, Lorenzo
Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts
2019-01-01 Wallace, Zs; Zhang, Y; Perugino, Ca; Naden, R; Choi, Hk; Stone, Jh; for the ACR/EULAR IgG4-RD Classification Criteria, Committee; DELLA TORRE, E
B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED DISEASE
2019-01-01 DELLA TORRE, E; Rigamonti, E; Perugino, C; Falconi, M; Stone, Jh; Manfredi, A; Pillai, S
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease
2019-01-01 DELLA TORRE, E; Elena, Rigamonti1; Simona Baghai, Sain3; Lanzillotta, Marco; Cory, Perugino2; John, Stone2; Falconi, Massimo; Shiv, Pillai2; Angelo, Manfredi1
Methotrexate as Induction of Remission Therapy for Type 1 Autoimmune Pancreatitis
2019-01-01 Rovati, L.; Lanzillotta, M.; Bozzolo, E.; Arcidiacono, P. G.; Falconi, M.; Dagna, L.; Della-Torre, E.; DELLA TORRE, Emanuel
B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease
2019-01-01 DELLA TORRE, E; Elena, Rigamonti; Cory, Perugino; Simona, Baghai Sain; Sun, Na; Naoki, Kaneko; Takashi, Maehara; Lucrezia Rovati, ; Ponzoni, Maurilio; Raffaella, Milani; Lanzillotta, Marco; Vinay Mahajan, ; Hamid, Mattoo; Ivan, Molineris; Vikram, Deshpande; John, H Stone; Falconi, Massimo; Manfredi, Angelo A.; Shiv, Pillai
Clonally Expanded CD4+ Cytotoxic T Cells, Endothelial Cell Apoptosis and the Pathogenesis of Early Systemic Sclerosis
2019-01-01 Takashi, Maehara; Cory, Perugino; Naoki, Kaneko; Hamid, Mattoo; Jesper, Kers; Hugues, Allard- Chamard; Vinay, Mahajan; Hang, Liu; Samuel, Murphy; Musie, Ghebremichael; Yesim, Tuncay; DELLA TORRE, E; Lloyd, Liang; Sydney, Montesi; Zachary, Wallace; David, Fox; Robert, Lafyatis; John, Stone; Dinesh Khanna and Shiv, Pillai
IGG4-RELATED DISEASE IN ITALY: RESULTS FROM A MONOCENTRIC COHORT OF 150 PATIENTS (2013–2018)
2019-01-01 Lanzillotta, Marco; DELLA TORRE, E; Corrado, Campochiaro; Enrica, Bozzolo; Dagna, Lorenzo
Malattia da IgG4
2020-01-01 DELLA TORRE, E
MAVRILIMUMAB IMPROVES OUTCOMES IN SEVERE COVID-19 PNEUMONIA AND SYSTEMIC HYPERINFLAMMATION
2020-01-01 De Luca, G.; Cavalli, G.; Campochiaro, C.; DELLA TORRE, E; Angelillo, P.; Tomelleri, A.; Boffini, N.; Tentori, S.; Mette, F.; Rovere-Querini, P.; Ruggeri, A.; D’Aliberti, T.; Scarpelllini, P.; Landoni, G.; De Cobelli, F.; Paolini, J. F.; Zangrillo, A.; Tresoldi, M.; Trapnell, B. C.; Ciceri, F.; Dagna, L.
European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations.
2020-01-01 Löhr, Jm; Beuers, U; Vujasinovic, M; Alvaro, D; Frøkjær, Jb; Buttgereit, F; Capurso, G; Culver, El; de-Madaria, E; DELLA TORRE, E; Detlefsen, S; Dominguez-Muñoz, E; Czubkowski, P; Ewald, N; Frulloni, L; Gubergrits, N; Duman, Dg; Hackert, T; Iglesias-Garcia, J; Kartalis, N; Laghi, A; Lammert, F; Lindgren, F; Okhlobystin, A; Oracz, G; Parniczky, A; Mucelli, Rmp; Rebours, V; Rosendahl, J; Schleinitz, N; Schneider, A; van Bommel, Ef; Verbeke, Cs; Vullierme, Mp; Witt, H; UEG guideline working, Group.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Iper IgG4 | 1-gen-2019 | DELLA TORRE, E | |
| La sindrome IgG4 una nuova sfida per l’internista e lo pneumologo | 1-gen-2019 | DELLA TORRE, E | |
| LONG-TERM EFFICACY OF RITUXIMAB MAINTENANCE THERAPY FOR IGG4- RELATED DISEASE RITUXIMAB MAINTENANCE THERAPY IN IGG4-RELATED DISEASE | 1-gen-2019 | Campochiaro, C.; DELLA TORRE, E; Lanzillotta, M.; Bozzolo, E. P.; Baldissera, E.; Milani, R.; Arcidiacono, P. G.; Crippa, S.; Falconi, M.; Dagna, L. | |
| CLINICAL MANIFESTATIONS OF IGG4-RELATED DISEASE ONSET REQUIRE ADMISSION TO THE EMERGENCY DEPARTMENT IN THE MAJORITY OF CASES. EXPERIENCE FROM A SINGLE ITALIAN REFERRAL CENTRE | 1-gen-2019 | Mancuso, G.; Lanzillotta, M.; Campochiaro, C.; Ramirez, G. A.; Bozzolo, E. P.; Dagna, L.; DELLA TORRE, E | |
| IMMUNOTERAPIA SPECIFICA E MALATTIA IgG4-CORRELATA: STUDIO EPIDEMIOLOGICO DI UN CENTRO DI RIFERIMENTO ITALIANO | 1-gen-2019 | DELLA TORRE, E; Germanò, Tommaso; Lanzillotta, Marco; Corrado, Campochiaro; Dagna, Lorenzo; Mona-Rita, Yacoub | |
| Malattia IgG4 correlata | 1-gen-2019 | DELLA TORRE, E | |
| La Malattia da IgG4 | 1-gen-2019 | DELLA TORRE, E | |
| Malattia sistemica e colangiopatia IgG4-relata | 1-gen-2019 | DELLA TORRE, E | |
| B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED DISEASE | 1-gen-2019 | DELLA TORRE, E; E., Rigamonti1; C., Perugino2; S., Baghai Sain1; L., Rovati1; Lanzillotta1, M.; Stone2, J. H.; Manfredi1, A. A.; S., Pillai2 | |
| EFFICACY AND SAFETY OF RITUXIMAB FOR INDUCTION OF REMISSION AND MAINTENANCE OF IGG4-RELATED DISEASE: EXPERIENCE FROM AN ITALIAN NATIONAL REFERRAL CENTRE | 1-gen-2019 | Corrado, Campochiaro; DELLA TORRE, E; Lanzillotta, Marco; Enrica, Bozzolo; Elena, Baldissera; Dagna, Lorenzo | |
| Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts | 1-gen-2019 | Wallace, Zs; Zhang, Y; Perugino, Ca; Naden, R; Choi, Hk; Stone, Jh; for the ACR/EULAR IgG4-RD Classification Criteria, Committee; DELLA TORRE, E | |
| B LYMPHOCYTES DIRECTLY CONTRIBUTE TO TISSUE FIBROSIS IN IGG4-RELATED DISEASE | 1-gen-2019 | DELLA TORRE, E; Rigamonti, E; Perugino, C; Falconi, M; Stone, Jh; Manfredi, A; Pillai, S | |
| B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease | 1-gen-2019 | DELLA TORRE, E; Elena, Rigamonti1; Simona Baghai, Sain3; Lanzillotta, Marco; Cory, Perugino2; John, Stone2; Falconi, Massimo; Shiv, Pillai2; Angelo, Manfredi1 | |
| Methotrexate as Induction of Remission Therapy for Type 1 Autoimmune Pancreatitis | 1-gen-2019 | Rovati, L.; Lanzillotta, M.; Bozzolo, E.; Arcidiacono, P. G.; Falconi, M.; Dagna, L.; Della-Torre, E.; DELLA TORRE, Emanuel | |
| B lymphocytes directly contribute to tissue fibrosis in IgG4-Related Disease | 1-gen-2019 | DELLA TORRE, E; Elena, Rigamonti; Cory, Perugino; Simona, Baghai Sain; Sun, Na; Naoki, Kaneko; Takashi, Maehara; Lucrezia Rovati, ; Ponzoni, Maurilio; Raffaella, Milani; Lanzillotta, Marco; Vinay Mahajan, ; Hamid, Mattoo; Ivan, Molineris; Vikram, Deshpande; John, H Stone; Falconi, Massimo; Manfredi, Angelo A.; Shiv, Pillai | |
| Clonally Expanded CD4+ Cytotoxic T Cells, Endothelial Cell Apoptosis and the Pathogenesis of Early Systemic Sclerosis | 1-gen-2019 | Takashi, Maehara; Cory, Perugino; Naoki, Kaneko; Hamid, Mattoo; Jesper, Kers; Hugues, Allard- Chamard; Vinay, Mahajan; Hang, Liu; Samuel, Murphy; Musie, Ghebremichael; Yesim, Tuncay; DELLA TORRE, E; Lloyd, Liang; Sydney, Montesi; Zachary, Wallace; David, Fox; Robert, Lafyatis; John, Stone; Dinesh Khanna and Shiv, Pillai | |
| IGG4-RELATED DISEASE IN ITALY: RESULTS FROM A MONOCENTRIC COHORT OF 150 PATIENTS (2013–2018) | 1-gen-2019 | Lanzillotta, Marco; DELLA TORRE, E; Corrado, Campochiaro; Enrica, Bozzolo; Dagna, Lorenzo | |
| Malattia da IgG4 | 1-gen-2020 | DELLA TORRE, E | |
| MAVRILIMUMAB IMPROVES OUTCOMES IN SEVERE COVID-19 PNEUMONIA AND SYSTEMIC HYPERINFLAMMATION | 1-gen-2020 | De Luca, G.; Cavalli, G.; Campochiaro, C.; DELLA TORRE, E; Angelillo, P.; Tomelleri, A.; Boffini, N.; Tentori, S.; Mette, F.; Rovere-Querini, P.; Ruggeri, A.; D’Aliberti, T.; Scarpelllini, P.; Landoni, G.; De Cobelli, F.; Paolini, J. F.; Zangrillo, A.; Tresoldi, M.; Trapnell, B. C.; Ciceri, F.; Dagna, L. | |
| European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations. | 1-gen-2020 | Löhr, Jm; Beuers, U; Vujasinovic, M; Alvaro, D; Frøkjær, Jb; Buttgereit, F; Capurso, G; Culver, El; de-Madaria, E; DELLA TORRE, E; Detlefsen, S; Dominguez-Muñoz, E; Czubkowski, P; Ewald, N; Frulloni, L; Gubergrits, N; Duman, Dg; Hackert, T; Iglesias-Garcia, J; Kartalis, N; Laghi, A; Lammert, F; Lindgren, F; Okhlobystin, A; Oracz, G; Parniczky, A; Mucelli, Rmp; Rebours, V; Rosendahl, J; Schleinitz, N; Schneider, A; van Bommel, Ef; Verbeke, Cs; Vullierme, Mp; Witt, H; UEG guideline working, Group. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile